Literature DB >> 12634939

Early rheumatoid arthritis patients: relationship of age.

Ioannis A Papadopoulos1, Pelagia Katsimbri, Yannis Alamanos, Paraskevi V Voulgari, Alexandros A Drosos.   

Abstract

The aim of this study was to investigate if age at disease onset comprises a separate parameter for disease expression, prognosis, and outcome in early rheumatoid arthritis (RA) patients. Four hundred thirty-eight patients with early RA (disease duration less than 1 year) were studied. All of them fulfilled the American College of Rheumatology criteria for RA. The demographic, clinical, laboratory, radiologic, and therapeutic characteristics of the disease at diagnosis and during and at the end of follow-up (time period 1981-2000) were analyzed according to age at disease onset (young patients aged less than 60 years at disease onset vs elderly patients aged more than 60 years at disease onset). We found 317 young and 121 elderly patients with early RA. The male:female ratio, which was 1:3.2 in the young patients, was nearly equal in the elderly (1:1.4). In addition, at disease onset elderly patients showed more severe joint involvement (decreased grip strength) associated with high titers of acute phase response (erythrocyte sedimentation rate and C-reactive protein) than the younger patients. However, there were no differences between the two groups in the numbers of tender and swollen joints or acute phase response at the end of the study period. Furthermore, no differences were seen between the two groups concerning the presence of rheumatoid factor. Finally, the two patient groups showed the same degree of radiological changes and functional ability and were treated similarly, except for more frequent corticosteroid use in the elderly. We conclude that elderly patients present with more severe joint involvement at disease onset. However, at the end of the study, no differences were seen concerning radiological changes and functional ability. It seems that age at disease onset does not influence the clinical course and outcome of early RA patients.

Entities:  

Mesh:

Year:  2002        PMID: 12634939     DOI: 10.1007/s00296-002-0251-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  Long term safety of etanercept in elderly subjects with rheumatic diseases.

Authors:  R Fleischmann; S W Baumgartner; M H Weisman; T Liu; B White; P Peloso
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

2.  Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials.

Authors:  Christopher J Edwards; Katherine Roshak; Jack F Bukowski; Ronald Pedersen; Mazhar Thakur; Cecilia Borlenghi; Cinzia Curiale; Heather Jones; Lisa Marshall
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

Review 3.  Management issues with elderly-onset rheumatoid arthritis: an update.

Authors:  Ignazio Olivieri; Carlo Palazzi; Giovanni Peruz; Angela Padula
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Older age of rheumatoid arthritis onset is associated with higher activation status of peripheral blood CD4(+) T cells and disease activity.

Authors:  J Pawłowska; Z Smoleńska; A Daca; J M Witkowski; E Bryl
Journal:  Clin Exp Immunol       Date:  2010-12-13       Impact factor: 4.330

5.  Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.

Authors:  Michael H Schiff; Elaine B Yu; Michael E Weinblatt; Larry W Moreland; Mark C Genovese; Barbara White; Amitabh Singh; Yun Chon; J Michael Woolley
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study.

Authors:  Christine G Parks; Brian T Walitt; Mary Pettinger; Jiu-Chiuan Chen; Anneclaire J de Roos; Julie Hunt; Gloria Sarto; Barbara V Howard
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-02       Impact factor: 4.794

Review 7.  Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives?

Authors:  Alexandros Drosos
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Patterns of biologic agent use in older males with inflammatory diseases: an institution-focused, observational post-marketing study.

Authors:  Suong Tran; Roderick S Hooker; Daisha J Cipher; Andreas Reimold
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 9.  Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.

Authors:  Roy Fleischmann; Imran Iqbal
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 10.  Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety.

Authors:  Beáta J Radovits; Wietske Kievit; Roland F J M Laan
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.